NCT02911818 - Lifestyle Modification and Liraglutide | Biotech Hunter

Enrollment

150

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

November 30, 2018

Study Completion Date

December 31, 2018

Conditions

Obesity

Interventions

BEHAVIORAL

CMS-recommended lifestyle counseling

21 brief (15 minute) lifestyle counseling visits provided by a physician, nurse practitioner, or registered dietitian.

DRUG

Liraglutide 3.0mg

Liraglutide is a once-daily self-administered, subcutaneous (beneath the skin) injection.

OTHER

Portion-Controlled Diet

A 1000-1200 kcal/day portion-controlled diet prescribed for 12 weeks.

DRUG

Placebo Oral Tablet

DRUG

Phentermine 15 MG

BEHAVIORAL

Extension Study CMS-recommended lifestyle counseling

4 brief (15 minute) lifestyle counseling visits provided by a physician, nurse practitioner, or registered dietitian.

Trial Locations (1)

University of Pennsylvania Center for Weight and Eating Disorders, Philadelphia